News

Ask the Doctor: There are several therapies now approved for relapsed/refractory DLBCL. What is a good way to determine which are the best options for me?

LRF grantee Jason Romancik, MD of the Winship Cancer Institute discusses these treatment options and what factors patients should consider when deciding what's right for them.

Ask the Doctor: How has frontline treatment for Hodgkin lymphoma evolved over the past five years?

LRF grantee Natalie Grover, MD of The University of North Carolina at Chapel Hill discusses the evolution of treatments in the past several years and the effect it has had on patients diagnosed with HL.

Ask the Doctor: Are there any oral therapies that are currently under investigation for frontline MCL?

LRF grantee Christina Lee, MD of the Memorial Sloan Kettering Cancer Center discusses the oral therapies that are currently under investigation for the treatment of frontline MCL and how this could help improve the treatment landscape for these patients.

CDC Updates COVID-19 Vaccine Recommendations for Moderately to Severely Immunocompromised People

People who have compromised immune systems may benefit from an additional dose to make sure they have enough protection against COVID-19.

LRF to Honor Leaders in Lymphoma at the 2021 Annual Gala on Sept. 30

Foundation to celebrate achievements of world-renowned hematologist and oncologist Christopher Flowers, MD and corporate patient supporter Kite

Laura Wallenstein Named Philanthropy Officer for the Lymphoma Research Foundation

Twenty-year career fundraising expert to spearhead development initiatives for national blood cancer organization.

Frank Recruitment Group Partners with Lymphoma Research Foundation to Raise Awareness and Funds for Lymphoma

Frank Recruitment Group’s partnership will take place across all nine of their U.S.-based offices and the company will participate in LRF events and initiatives such as Lymphoma Walks, the Lymphoma Research Ride, Fundraise Your Way, Blood Cancer Awareness Month, and National Cancer Survivors Day.

News

Ask the Doctor: There are several therapies now approved for relapsed/refractory DLBCL. What is a good way to determine which are the best options for me?

Ask the Doctor: How has frontline treatment for Hodgkin lymphoma evolved over the past five years?

Ask the Doctor: Are there any oral therapies that are currently under investigation for frontline MCL?

CDC Updates COVID-19 Vaccine Recommendations for Moderately to Severely Immunocompromised People

LRF to Honor Leaders in Lymphoma at the 2021 Annual Gala on Sept. 30

Laura Wallenstein Named Philanthropy Officer for the Lymphoma Research Foundation

Frank Recruitment Group Partners with Lymphoma Research Foundation to Raise Awareness and Funds for Lymphoma

CDC Updates COVID-19 Vaccine Guidance for Immunocompromised

Meet the 2021 Lymphoma Scientific Research Mentoring Program Scholars

Glass Half Full: A Story of Hope

Subscribe to Our Emails. Get lymphoma and CLL resources and updates.